Cargando…

Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions

BACKGROUND & AIMS: Despite availability of diagnostic and management reference guidelines outlining standard of care for patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), national and regional guidelines are lacking, resulting in variations in pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anstee, Quentin M., Hallsworth, Kate, Lynch, Niall, Hauvespre, Adrien, Mansour, Eid, Kozma, Sam, Marino, John-Paul, Bottomley, Juliana, Piercy, James, Higgins, Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686034/ https://www.ncbi.nlm.nih.gov/pubmed/34977520 http://dx.doi.org/10.1016/j.jhepr.2021.100411

Ejemplares similares

Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey
por: Anstee, Quentin M, et al.
Publicado: (2023)

Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial
por: Houghton, David, et al.
Publicado: (2017)

Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait
por: Sanai, Faisal M., et al.
Publicado: (2021)

Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study
por: Hallsworth, Kate, et al.
Publicado: (2019)

Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping
por: Hallsworth, Kate, et al.
Publicado: (2021)

Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH
por: Fishman, Jesse, et al.
Publicado: (2023)

Hepatitis B care pathway in Jordan: current situation, gaps and recommended actions
por: Nusair, Majed, et al.
Publicado: (2020)

A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH)
por: Povsic, Manca, et al.
Publicado: (2019)

A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH)
por: Povsic, Manca, et al.
Publicado: (2019)

Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
por: Twiss, James, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls
por: Hallsworth, Kate, et al.
Publicado: (2015)

Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
por: Scragg, Jadine, et al.
Publicado: (2021)

Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic Steatohepatitis
por: Jacobson, Ira M., et al.
Publicado: (2022)

Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study
por: Doward, Lynda C., et al.
Publicado: (2020)

Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
por: O'Hara, Jamie, et al.
Publicado: (2020)

Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease
por: Scragg, Jadine, et al.
Publicado: (2020)

Guideline-Recommended Medications: Variation Across Medicare Advantage Plans and Associated Mortality
por: Selim, Alfredo J., et al.
Publicado: (2013)

Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary–secondary care interface
por: McPherson, Stuart, et al.
Publicado: (2023)

Updated recommendations: an assessment of NICE clinical guidelines
por: Martínez García, Laura, et al.
Publicado: (2014)

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
por: McPherson, Stuart, et al.
Publicado: (2017)

Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis
por: Lee, Jenny, et al.
Publicado: (2020)

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient‐Reported Outcomes
por: Younossi, Zobair M, et al.
Publicado: (2020)

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
por: Sanyal, Arun J., et al.
Publicado: (2022)

Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?
por: Wessels, David Hermanus, et al.
Publicado: (2021)

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
por: Siddiqui, Mohammad Shadab, et al.
Publicado: (2018)

Recommended guidance beyond guidelines
por: Höschl, Cyril
Publicado: (2010)

Concordance of recommendations across clinical practice guidelines for the management of hypertension in Southeast Asia with internationally reputable sources
por: Kow, Chia Siang, et al.
Publicado: (2021)

Women’s perceptions of antenatal care: are we following guideline recommended care?
por: Waller, Amy, et al.
Publicado: (2016)

Clinical practice guideline on pregnancy and renal disease
por: Wiles, Kate, et al.
Publicado: (2019)

Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease
por: Karsdal, Morten A., et al.
Publicado: (2023)

Management of multidrug-resistant tuberculosis: main recommendations of the Brazilian guidelines
por: Ballestero, Jaqueline Garcia de Almeida, et al.
Publicado: (2020)

Quality Standards for the Management of NAFLD: Consensus Recommendations from the British Association for the Study of the Liver (BASL) and British Society of Gastroenterology (BSG) NAFLD Special Interest Group
por: McPherson, Stuart, et al.
Publicado: (2022)

Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan
por: DiBonaventura, Marco D, et al.
Publicado: (2019)

Evidence‐based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines
por: Corp, Nadia, et al.
Publicado: (2020)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Guidelines and recommendations on hormone therapy in the menopause
por: Pines, Amos
Publicado: (2010)

Paracetamol: A Review of Guideline Recommendations
por: Freo, Ulderico, et al.
Publicado: (2021)

The dissemination of brain imaging guidelines and recommendations
por: Yeung, Andy Wai Kan, et al.
Publicado: (2021)

Increasing the usefulness of acupuncture guideline recommendations
por: Zhang, Yu-Qing, et al.
Publicado: (2022)

Prioritizing guideline recommendations for implementation: a systematic, consumer-inclusive process with a case study using the Australian Clinical Guidelines for Stroke Management
por: Lynch, Elizabeth A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qitsehq16e3c5e01vb7a6m6oeu